PRPH ProPhase Labs, Inc.

Nasdaq prophaselabs.com


$ 0.40 $ -0.01 (-1.98 %)    

Wednesday, 22-Oct-2025 15:17:30 EDT
QQQ $ 604.03 $ -6.73 (-1.1 %)
DIA $ 465.75 $ -3.47 (-0.74 %)
SPY $ 666.88 $ -5.04 (-0.75 %)
TLT $ 92.13 $ 0.13 (0.14 %)
GLD $ 376.34 $ 3.47 (0.93 %)
$ 0.5109
$ 0.42
$ 0.40 x 200
$ 0.40 x 100
$ 0.38 - $ 0.42
$ 0.22 - $ 2.45
1,233,825
na
21.22M
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-20-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-19-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-12-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-20-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-28-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 02-24-2017 12-31-2016 10-K
36 11-15-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-13-2016 03-31-2016 10-Q
39 03-29-2016 12-31-2015 10-K
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 prophase-labs-entered-into-sales-agreement-with-westpark-capital-relating-to-shares-of-common-stock-offered-by-prospectus-supplement--may-offer-and-sell-shares-of-common-stock-from-time-to-time-up-to-43m

https://www.sec.gov/Archives/edgar/data/868278/000149315225018187/form424b5.htm

 prophase-labs-shareholders-approve-strategic-expansion-including-increase-in-authorized-shares-to-1b

ProPhase Labs Stockholders Deliver Strong Mandate at Special MeetingUNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase ...

 prophase-labs-q2-eps-011-beats-015-estimate-sales-1247m-may-not-be-comparable-to-3550m-estimate

The Company did not generate any revenues from diagnostic services for the three months ended June 30, 2025 and 2024, respectiv...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION